Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alberto Ardura-Fabregat, Erik Boddeke, Antonio Boza‐Serrano, et al.
CNS Drugs (2017) Vol. 31, Iss. 12, pp. 1057-1082
Open Access | Times Cited: 205

Showing 51-75 of 205 citing articles:

UHPLC-MS/MS analysis and protective effects on neurodegenerative diseases of phenolic compounds in different parts of Diospyros kaki L. cv. Mopan
Jian Zhao, Zhongling Chen, Lingxi Li, et al.
Food Research International (2024) Vol. 184, pp. 114251-114251
Closed Access | Times Cited: 7
Neuroinflammation: A Critical Factor in Neurodegenerative Disorders
Zahieh Suleiman Khoury, Fatima Sohail, Jada Wang, et al.
Cureus (2024)
Open Access | Times Cited: 7
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 21, pp. 3800-3827
Open Access | Times Cited: 6
The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
Johanna Michael, Julia Marschallinger, Ludwig Aigner
Drug Discovery Today (2018) Vol. 24, Iss. 2, pp. 505-516
Open Access | Times Cited: 57
Neuronal specific and non-specific responses to cadmium possibly involved in neurodegeneration: A toxicogenomics study in a human neuronal cell model
Matilde Forcella, Pierre Lau, Monica Oldani, et al.
NeuroToxicology (2019) Vol. 76, pp. 162-173
Open Access | Times Cited: 54
The depressor axis of the renin–angiotensin system and brain disorders: a translational approach
Mariela M. Gironacci, Augusto Vicario, Gustavo H. Cerezo, et al.
Clinical Science (2018) Vol. 132, Iss. 10, pp. 1021-1038
Open Access | Times Cited: 53
Extracellular tau induces microglial phagocytosis of living neurons in cell cultures
Katryna Pampuščenko, Ramunė Morkūnienė, Tomas Šneideris, et al.
Journal of Neurochemistry (2019) Vol. 154, Iss. 3, pp. 316-329
Open Access | Times Cited: 53
Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach
Benjamin A. Logsdon, Thanneer M. Perumal, Vivek Swarup, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 51
Gut microbiome: An intermediary to neurotoxicity
Joseph L. Dempsey, Mallory Little, Julia Yue Cui
NeuroToxicology (2019) Vol. 75, pp. 41-69
Open Access | Times Cited: 50
The Impact of Air Pollution on Neurodegenerative Diseases
Jian Wang, Tengfei Ma, Ding Ma, et al.
Therapeutic Drug Monitoring (2020) Vol. 43, Iss. 1, pp. 69-78
Closed Access | Times Cited: 49
5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer’s Disease
Zahra Manji, Asheebo Rojas, Wenyi Wang, et al.
Journal of Alzheimer s Disease (2019) Vol. 70, Iss. 4, pp. 1259-1274
Open Access | Times Cited: 45
Retinal correlates of psychiatric disorders
Melanie Almonte, Pamela Capellàn, Timothy E. Yap, et al.
Therapeutic Advances in Chronic Disease (2020) Vol. 11
Open Access | Times Cited: 45
Inhibition of Amyloid-Beta Production, Associated Neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology in Alzheimer’s Disease in vitro Model
Venkata Atluri, Sneham Tiwari, Melisa Rodriguez, et al.
Frontiers in Aging Neuroscience (2020) Vol. 11
Open Access | Times Cited: 43
Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
Kelly Ceyzériat, Thomas Zilli, P. Millet, et al.
Current Alzheimer Research (2020) Vol. 17, Iss. 2, pp. 112-125
Closed Access | Times Cited: 43
Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration
Alexander D. Landgraf, Amsha S. Alsegiani, Saleh Alaqel, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 19, pp. 3008-3016
Open Access | Times Cited: 42
Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer’s disease
Merve Erdoğan, Burcu Kılıç, Rahşan Ilıkçı Saǧkan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 113124-113124
Closed Access | Times Cited: 42
Curcumin improves memory deficits by inhibiting HMGB1‐RAGE/TLR4‐NF‐κB signalling pathway in APPswe/PS1dE9 transgenic mice hippocampus
Yuan Han, Rui Chen, Qi-Cheng Lin, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 18, pp. 8947-8956
Open Access | Times Cited: 36
Neuroprotective Effect of Terpenoids Recovered from Olive Oil By-Products
Zully J. Suárez Montenegro, Gerardo Álvarez‐Rivera, José David Sánchez-Martínez, et al.
Foods (2021) Vol. 10, Iss. 7, pp. 1507-1507
Open Access | Times Cited: 35
HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation
Jae‐Ho Jeong, Dong Hoon Lee, Juhyun Song
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112933-112933
Open Access | Times Cited: 25
Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
Lucia Princiotta Cariddi, M. Mauri, Marco Cosentino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13008-13008
Open Access | Times Cited: 24
Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer’s disease
Henrique Correia Campos, Deidiane Elisa Ribeiro, Debora Hashiguchi, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 13
Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota–gut–brain axis
Lina Ma, Xuefan Jiang, Qiao-yi Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115244-115244
Open Access | Times Cited: 13
Alleviation of Cognitive Impairment-like Behaviors, Neuroinflammation, Colitis, and Gut Dysbiosis in 5xFAD Transgenic and Aged Mice by Lactobacillus mucosae and Bifidobacterium longum
Xiaoyang Ma, Jeon-Kyung Kim, Yoon-Jung Shin, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3381-3381
Open Access | Times Cited: 13
Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)
Yujia Zheng, Xiaolu Zhang, Ruifeng Zhang, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 5
Open Access | Times Cited: 13
Mode of administration influences plasma levels of active Centella asiatica compounds in 5xFAD mice while markers of neuroinflammation remain unaltered
Alex Speers, Kirsten M. Wright, Mikah S. Brandes, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5

Scroll to top